Voglibose is a therapeutic drug used to lower blood glucose levels after consuming food in people suffering from Type 2 diabetes, Diabetes Mellitus.It is an alpa-glucosidase inhibitor. Sugar absorption is delayed as voglibose regulates the intestinal enzymes from breaking down complex carbs to simpler carbs such as glucose. Hence there is no immediate surge in glucose levels immediately after the consumption of food. Japan’s largest pharmaceutical company designed this drug in 1981 and was released to the market in 1994 with the trade name Basen.
Some uses and benefits of voglibose are:
For optimal benefits, you must take this medication as prescribed by the physician in its recommended dosage along with proper diet and exercise.
Some of the common side effects of voglibose include:
Medical attention is not needed in these common side effects but in case of serious problems contact our experts at Yashoda hospitals.
Precautions – While on this drug, precaution must be taken if you are suffering from ulcers, ketosis, digestive disorders, diabetes, hypersensitivity, irritable bowel syndrome, and liver disease. For more information on the dosages and precautions necessary for consuming voglibose, contact our medical experts at Yashoda Hospitals.
1. Are voglibose voglitor and volibo same?
Yes, voglibose, voglitor, and volibo are all different brand names of the same drug. They all belong to a group of anti-diabetic medicines called alpha-glucosidase inhibitors used to treat type-2 diabetes mellitus.Type-2 diabetes is also referred to as non-insulin-dependent diabetes—these drugs, together with proper diet and exercise, help in regulating blood sugar.
2. Can I take glibenclamide with voglibose?
In combination with metformin and Voglibose, Glibenclamide is an ideal drug that works efficiently in controlling type 2 diabetes. Each of them works differently, but together; they are better at controlling sugar in the blood when single or dual drug therapy does not seem to work.
3. Can we use voglibose in chronic kidney disease(CKD)?
NO, you cannot use voglibose in chronic kidney disease. Kidney has the main role in eliminating medications used for treating diabetes. However, in patients suffering from chronic kidney disease, accumulation of drugs occurs. Accumulation of voglibose does not occur in patients suffering from chronic kidney disease. Edema and heart failure might occur. It is therefore better to avoid this drug in patients suffering from CKD.
4. Does voglibose cause dizziness?
Voglibose, an alpha-glucosidase inhibitor, was shown to cause dizziness immediately after treatment with it. Although dizziness does not occur constantly, a case study of two very old patients that showed severe dizziness was reported.
5. How do you take voglibose?
Voglibose, a drug used to control sugar breakdown in the intestine in patients suffering from type 2 diabetes mellitus is to be taken orally before consuming food three times a day. It is generally recommended to take 0.2mg in adults; however the right dosage is given to the doctor depending on the patient’s conditions.
6. Does voglibose cause a burning sensation in the stomach?
Voglibose is a well-tolerated blood sugar-reducing therapeutic drug used to treat patients with diabetes mellitus. Once on this medicine, side effects such as burning sensation in the stomach and flatulence may occur, but gradually, this side effect might be reduced. If the pain persists, you should consult your doctor.
7. When should voglibose be taken?
Voglibose is taken before each meal three times a day.0.2 mg of voglibose is recommended for older patients three times before each meal. The doctor decides the frequency and right dose to ensure the right amount is to be consumed so that sugar levels come down.
8. Which is better, voglibose or teneligliptin?
Teneligliptin is a DPP-4 inhibitor developed recently in September 2012. Its special structure enables it to have enhanced potency and selectivity. Five consecutive rings help in acting on the S2 extensive subunit of DPP-4. Side effects are lesser. Comparative studies with teneligliptin and other DPP-4 inhibitors on glucose-lowering effects showed teneligliptin to be more efficient than voglibose.
9. What drug class is voglibose?
Voglibose belongs to a family of competitive alpha-glucosidase inhibitors. This family of drugs lowers postprandial blood glucose levels. These drugs slow down the absorption of sugar and thereby the risk of developing macrovascular complications.
10. Is voglibose safe?
Voglibose is one of the best therapeutic options for patients with Diabetes Mellitus type 2 when diet alone and other medicines sulfonylurea and biguanide do not work well. It rarely has side effects and is the best therapeutic medicine in that family. The complication in diabetes arises from poor regulation of postprandial hyperglycemia.
Disclaimer: The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.